Bartlett & Co. LLC Astrazeneca PLC Transaction History

Bartlett & Co. LLC

$6.16 Billion
Q4 2023

A detailed history of Bartlett & Co. LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Bartlett & Co. LLC holds 1,579 shares of AZN stock, worth $141,162. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,579

Previous 792 99.37%

Holding current value

$141,162

Previous $54,000 96.3%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 08, 2024	BUY	$61.89 - $69.28 $48,707 - $54,523	787 Added 99.37%	1,579 $106,000
Q2 2023 Jul 14, 2023	BUY	$69.91 - $75.81 $11,814 - $12,811	169 Added 27.13%	792 $57,000
Q1 2022 May 13, 2022	BUY	$55.72 - $67.12 $34,713 - $41,815	623 New	623 $41,000
Q4 2021 Mar 08, 2022	SELL	$54.02 - $63.83 $33,654 - $39,766	-623 Closed	0 $0
Q3 2021 Oct 15, 2021	BUY	$55.56 - $60.79 $1,500 - $1,641	27 Added 4.53%	623 $37,000

Q4 2020 Jan 20, 2021	BUY	$48.52 - $58.02 $2,086 - $2,494	43 Added 7.78%	596 $30,000
Q3 2020 Oct 20, 2020	BUY	$53.07 - $61.1 $5,307 - $6,110	100 Added 22.08%	553 $30,000
Q2 2020 Aug 03, 2020	SELL	$43.1 - $55.31 $1,034 - $1,327	-24 Reduced 5.03%	453 $24,000
Q1 2020 May 07, 2020	BUY	$37.79 - $51.33 $906 - $1,231	24 Added 5.3%	477 $21,000
Q3 2019 Nov 04, 2019	BUY	$40.12 - $45.47 $18,174 - $20,597	453 New	453 $20,000
Q2 2019 Jul 24, 2019	SELL	$37.28 - $41.68 $2,423 - $2,709	-65 Closed	0 $0
Q1 2019 Apr 23, 2019	SELL	$35.49 - $43.02 $54,477 - $66,035	-1,535 Reduced 95.94%	65 $0
Q3 2018 Oct 15, 2018	BUY	$34.76 - $39.72 $55,616 - $63,552	1,600 New	1,600 $63,000

Others Institutions Holding AZN

# of Institutions

1,505

Shares Held

501M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bartlett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bartlett & Co. LLC with notifications on news.

Account